FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium ,...
Saved in:
Published in | Nature communications Vol. 13; no. 1; pp. 1425 - 12 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
17.03.2022
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from
Faecalibaculum rodentium
, which is characterized by a simple PAM (5′-NNTA-3′) and a guide RNA length of 21–22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics.
Gene editing tools have tremendous potential for biomedical and basic research. Here the authors report a Cas9 from
Faecalibaculum rodentium
(FrCas9) that achieves efficient and specific gene editing in human cells with a NNTA palindrome PAMs for targeting optimal sites at TATA-boxes to enhance CRISPRa/i screening. |
---|---|
AbstractList | Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium, which is characterized by a simple PAM (5'-NNTA-3') and a guide RNA length of 21-22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics. Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium, which is characterized by a simple PAM (5′-NNTA-3′) and a guide RNA length of 21–22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics.Gene editing tools have tremendous potential for biomedical and basic research. Here the authors report a Cas9 from Faecalibaculum rodentium (FrCas9) that achieves efficient and specific gene editing in human cells with a NNTA palindrome PAMs for targeting optimal sites at TATA-boxes to enhance CRISPRa/i screening. Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium , which is characterized by a simple PAM (5′-NNTA-3′) and a guide RNA length of 21–22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics. Gene editing tools have tremendous potential for biomedical and basic research. Here the authors report a Cas9 from Faecalibaculum rodentium (FrCas9) that achieves efficient and specific gene editing in human cells with a NNTA palindrome PAMs for targeting optimal sites at TATA-boxes to enhance CRISPRa/i screening. Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium , which is characterized by a simple PAM (5′-NNTA-3′) and a guide RNA length of 21–22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics. Gene editing tools have tremendous potential for biomedical and basic research. Here the authors report a Cas9 from Faecalibaculum rodentium (FrCas9) that achieves efficient and specific gene editing in human cells with a NNTA palindrome PAMs for targeting optimal sites at TATA-boxes to enhance CRISPRa/i screening. Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium, which is characterized by a simple PAM (5'-NNTA-3') and a guide RNA length of 21-22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics.Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium, which is characterized by a simple PAM (5'-NNTA-3') and a guide RNA length of 21-22 bp. We find that FrCas9 could achieve comparable efficiency and specificity to SpCas9. Interestingly, the PAM of FrCas9 presents a palindromic sequence, which greatly expands its targeting scope. Due to the PAM sequence, FrCas9 possesses double editing-windows for base editor and could directly target the TATA-box in eukaryotic promoters for TATA-box related diseases. Together, our results broaden the understanding of CRISPR/Cas-mediated genome engineering and establish FrCas9 as a safe and efficient platform for wide applications in research, biotechnology and therapeutics. |
ArticleNumber | 1425 |
Author | Li, Lifang Weng, Haiyan Huang, Zheying Zhou, Rong Xie, Hongxian Lang, Bin Huang, Zhaoyue Tian, Rui Liu, Jiashuo Liu, Dan Mo, Haiyan Cui, Zifeng Jin, Zhuang Hu, Zheng Meng, Bo |
Author_xml | – sequence: 1 givenname: Zifeng surname: Cui fullname: Cui, Zifeng organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University – sequence: 2 givenname: Rui surname: Tian fullname: Tian, Rui organization: Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Sun Yat-sen University Nanchang Research Institution – sequence: 3 givenname: Zhaoyue surname: Huang fullname: Huang, Zhaoyue organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University – sequence: 4 givenname: Zhuang surname: Jin fullname: Jin, Zhuang organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University – sequence: 5 givenname: Lifang surname: Li fullname: Li, Lifang organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University – sequence: 6 givenname: Jiashuo surname: Liu fullname: Liu, Jiashuo organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University – sequence: 7 givenname: Zheying surname: Huang fullname: Huang, Zheying organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University – sequence: 8 givenname: Hongxian surname: Xie fullname: Xie, Hongxian organization: Generulor Company Bio-X Lab – sequence: 9 givenname: Dan surname: Liu fullname: Liu, Dan organization: Generulor Company Bio-X Lab – sequence: 10 givenname: Haiyan surname: Mo fullname: Mo, Haiyan organization: Generulor Company Bio-X Lab – sequence: 11 givenname: Rong surname: Zhou fullname: Zhou, Rong organization: Generulor Company Bio-X Lab – sequence: 12 givenname: Bin surname: Lang fullname: Lang, Bin organization: School of Health Sciences and Sports, Macao Polytechnic Institute – sequence: 13 givenname: Bo surname: Meng fullname: Meng, Bo organization: Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China – sequence: 14 givenname: Haiyan surname: Weng fullname: Weng, Haiyan email: whaiyan1166@163.com organization: Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China – sequence: 15 givenname: Zheng orcidid: 0000-0001-9306-9442 surname: Hu fullname: Hu, Zheng email: huzheng1998@163.com organization: Department of Gynecological oncology, the First Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University Nanchang Research Institution |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35301321$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uk1vEzEUtFARLaV_gANaiQuXpf5c2xckFFEaqRKowNny-mPjaOMttlOUf4-TLaXtob746Xlm3tie1-AoTtEB8BbBjwgScZ4poh1vIcYtllDIVrwAJxhS1CKOydGD-hic5byGdRGJBKWvwDFhBCKC0Qm4vEgLnWUTcqObxfXyx_fr80Mj73Jxm-ZPKKtmFYZV42woIQ6N8z6Y4KLZNTraxgfrxlB2b8BLr8fszu72U_Dr4svPxWV79e3rcvH5qjWMwtISQazr6nDaEyYs51QzaQ3ve-m8cL1kfQeJ1kZ7BH0vOuEZs1I4yGXXU05OwXLWtZNeq5sUNjrt1KSDOjSmNCidSjCjU0yTXtjOUC487ZgX2CDLKDWmVg6bqvVp1rrZ9htnjYsl6fGR6OOTGFZqmG6VkAQhKqrAhzuBNP3eulzUJmTjxlFHN22zwh2FUhLKYYW-fwJdT9sU61MdUEzijrOKevfQ0b2Vfx9WAXgGmDTlnJy_hyCo9sFQczBUDYY6BEPtbYonJBOKLmHa3yqMz1PJTM11Thxc-m_7GdZfESXKhA |
CitedBy_id | crossref_primary_10_3390_pharmaceutics16020213 crossref_primary_10_59786_bmtj_221 crossref_primary_10_3390_ijms242216077 crossref_primary_10_1016_j_bcab_2025_103553 crossref_primary_10_1016_j_tim_2024_05_004 crossref_primary_10_1186_s43556_023_00115_5 crossref_primary_10_1007_s42994_024_00157_5 crossref_primary_10_1016_j_biotechadv_2025_108557 crossref_primary_10_1016_j_crmeth_2023_100444 crossref_primary_10_1094_MPMI_05_23_0072_SC crossref_primary_10_1038_s42003_022_04258_z crossref_primary_10_1021_acssynbio_3c00698 crossref_primary_10_1080_15476286_2023_2256578 crossref_primary_10_1038_s41580_025_00834_3 crossref_primary_10_1038_s42003_025_07893_4 crossref_primary_10_31857_S0026898423030163 crossref_primary_10_3390_ijms25010607 crossref_primary_10_1111_pbi_14363 crossref_primary_10_1016_j_medj_2023_05_005 crossref_primary_10_3390_ijms23158684 crossref_primary_10_1186_s12967_024_05570_4 crossref_primary_10_3390_cells11142186 crossref_primary_10_1021_acssynbio_3c00501 crossref_primary_10_1021_acssynbio_3c00141 crossref_primary_10_1134_S0026893323030147 crossref_primary_10_1016_j_celrep_2024_113765 crossref_primary_10_1038_s41467_025_56655_7 |
Cites_doi | 10.1126/sciadv.aau0766 10.2302/kjm.2019-0009-OA 10.1038/nature16526 10.1126/science.aad5227 10.1038/nbt.2675 10.1126/science.1225829 10.1038/nmeth.2681 10.1093/nar/gki408 10.1186/s13059-019-1620-8 10.1016/j.cell.2015.09.038 10.1016/j.molcel.2016.12.023 10.1126/science.1231143 10.1038/s41467-017-01408-4 10.1073/pnas.1313587110 10.1038/nature24644 10.1093/nar/gkv1222 10.1093/nar/gky425 10.1093/nar/gkf436 10.1093/bioinformatics/bty560 10.1038/nbt.3437 10.1093/nar/gkaa998 10.1172/JCI78206 10.1038/s41596-020-00465-2 10.1093/bioinformatics/btu379 10.1016/j.cell.2014.05.010 10.1038/nbt.3117 10.1016/j.cell.2014.02.001 10.1002/humu.22535 10.1016/j.ebiom.2020.102897 10.1038/nbt.3534 10.1038/nature14592 10.1038/nmeth.1318 10.1186/s13059-020-01989-2 10.1038/s41467-020-19344-1 10.1126/sciadv.aao4774 10.1134/S0006297909020011 10.1093/molbev/msp077 10.1101/gr.162339.113 10.1038/nchembio.2559 10.1099/ijsem.0.001793 10.1371/journal.pone.0040913 10.1002/jcc.21596 10.1016/j.antiviral.2020.104794 10.1038/ncomms14500 10.1038/nature21059 10.1093/bioinformatics/btp324 10.7150/ijbs.24581 10.1038/nbt.2647 10.1093/bioinformatics/bts635 10.1038/nbt.2808 10.1093/bioinformatics/btr507 10.1093/database/baz093 10.1101/pdb.prot086785 |
ContentType | Journal Article |
Copyright | The Author(s) 2022 2022. The Author(s). The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 5PM DOA |
DOI | 10.1038/s41467-022-29089-8 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-1723 |
EndPage | 12 |
ExternalDocumentID | oai_doaj_org_article_5a3b8d6c478f465f82c1d544cc82ce2c PMC8931148 35301321 10_1038_s41467_022_29089_8 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AARCD AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PKEHL PQEST PQUKI PRINS RC3 SOI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c540t-383de60134b358d774a59dc7bb9ef8eb95b603aacaf10fb868f55d98e0796b473 |
IEDL.DBID | M48 |
ISSN | 2041-1723 |
IngestDate | Wed Aug 27 01:13:37 EDT 2025 Thu Aug 21 14:14:36 EDT 2025 Fri Jul 11 11:18:00 EDT 2025 Wed Aug 13 11:00:16 EDT 2025 Mon Jul 21 05:34:08 EDT 2025 Tue Jul 01 04:17:46 EDT 2025 Thu Apr 24 22:50:29 EDT 2025 Fri Feb 21 02:38:39 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2022. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-383de60134b358d774a59dc7bb9ef8eb95b603aacaf10fb868f55d98e0796b473 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-9306-9442 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41467-022-29089-8 |
PMID | 35301321 |
PQID | 2640592675 |
PQPubID | 546298 |
PageCount | 12 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5a3b8d6c478f465f82c1d544cc82ce2c pubmedcentral_primary_oai_pubmedcentral_nih_gov_8931148 proquest_miscellaneous_2640993470 proquest_journals_2640592675 pubmed_primary_35301321 crossref_primary_10_1038_s41467_022_29089_8 crossref_citationtrail_10_1038_s41467_022_29089_8 springer_journals_10_1038_s41467_022_29089_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-17 |
PublicationDateYYYYMMDD | 2022-03-17 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-17 day: 17 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature communications |
PublicationTitleAbbrev | Nat Commun |
PublicationTitleAlternate | Nat Commun |
PublicationYear | 2022 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Gibson (CR45) 2009; 6 Kim (CR13) 2017; 8 CR34 Hsu (CR5) 2013; 31 Zadeh (CR36) 2011; 32 Zetsche, Abudayyeh, Gootenberg, Scott, Zhang (CR19) 2020; 69 Fu, Sander, Reyon, Cascio, Joung (CR8) 2014; 32 Teng (CR18) 2019; 20 Hsu, Lander, Zhang (CR1) 2014; 157 Tsai (CR4) 2015; 33 Cox (CR20) 2017; 67 Li, Durbin (CR50) 2009; 25 Jinek (CR3) 2012; 337 Chen (CR52) 2020; 178 Soding, Biegert, Lupas (CR37) 2005; 33 Slaymaker (CR9) 2016; 351 Nishimasu (CR26) 2014; 156 Smargon (CR47) 2017; 65 Couvin (CR35) 2018; 46 Chen, Zhou, Chen, Gu (CR48) 2018; 34 Chen (CR16) 2020; 21 You (CR51) 2018; 14 Niu (CR25) 2020; 58 Walton, Hsu, Joung, Kleinstiver (CR24) 2021; 16 Magadan, Dupuis, Villion, Moineau (CR41) 2012; 7 Magoc, Salzberg (CR49) 2011; 27 Burstein (CR23) 2017; 542 Gasiunas (CR40) 2020; 11 Yin (CR11) 2018; 14 Chatterjee, Jakimo, Jacobson (CR42) 2018; 4 Phanstiel, Boyle, Araya, Snyder (CR44) 2014; 30 Tsai, Topkar, Joung, Aryee (CR53) 2016; 34 Hu (CR27) 2015; 125 Landrum (CR31) 2016; 44 Cho (CR10) 2014; 24 Zetsche (CR17) 2015; 163 Katoh, Misawa, Kuma, Miyata (CR39) 2002; 30 Fedorova (CR14) 2020; 48 Kleinstiver (CR7) 2016; 529 Kleinstiver (CR46) 2015; 523 Esvelt (CR22) 2013; 10 Cong (CR2) 2013; 339 Hou (CR12) 2013; 110 Harrington (CR15) 2017; 8 Dobin (CR43) 2013; 29 CR21 Gaudelli (CR30) 2017; 551 Price, Dehal, Arkin (CR38) 2009; 26 Doench (CR6) 2016; 34 Drachkova (CR32) 2014; 35 Savinkova (CR33) 2009; 74 Mali (CR28) 2013; 31 Komor (CR29) 2017; 3 KM Esvelt (29089_CR22) 2013; 10 Z Hu (29089_CR27) 2015; 125 MJ Landrum (29089_CR31) 2016; 44 BP Kleinstiver (29089_CR7) 2016; 529 K Katoh (29089_CR39) 2002; 30 I Drachkova (29089_CR32) 2014; 35 BP Kleinstiver (29089_CR46) 2015; 523 MN Price (29089_CR38) 2009; 26 LK Savinkova (29089_CR33) 2009; 74 SQ Tsai (29089_CR53) 2016; 34 H Yin (29089_CR11) 2018; 14 RT Walton (29089_CR24) 2021; 16 L Cong (29089_CR2) 2013; 339 F Teng (29089_CR18) 2019; 20 B Zetsche (29089_CR17) 2015; 163 A Dobin (29089_CR43) 2013; 29 IM Slaymaker (29089_CR9) 2016; 351 B Zetsche (29089_CR19) 2020; 69 AC Komor (29089_CR29) 2017; 3 JN Zadeh (29089_CR36) 2011; 32 G Niu (29089_CR25) 2020; 58 LB Harrington (29089_CR15) 2017; 8 PD Hsu (29089_CR1) 2014; 157 DH Phanstiel (29089_CR44) 2014; 30 G Gasiunas (29089_CR40) 2020; 11 S Chen (29089_CR48) 2018; 34 SQ Tsai (29089_CR4) 2015; 33 AH Magadan (29089_CR41) 2012; 7 P Mali (29089_CR28) 2013; 31 PD Hsu (29089_CR5) 2013; 31 D Couvin (29089_CR35) 2018; 46 P Chatterjee (29089_CR42) 2018; 4 29089_CR21 AA Smargon (29089_CR47) 2017; 65 M Jinek (29089_CR3) 2012; 337 JG Doench (29089_CR6) 2016; 34 LM Cox (29089_CR20) 2017; 67 J Soding (29089_CR37) 2005; 33 H Li (29089_CR50) 2009; 25 H Nishimasu (29089_CR26) 2014; 156 T Magoc (29089_CR49) 2011; 27 Z Hou (29089_CR12) 2013; 110 I Fedorova (29089_CR14) 2020; 48 Q You (29089_CR51) 2018; 14 NM Gaudelli (29089_CR30) 2017; 551 E Kim (29089_CR13) 2017; 8 Y Chen (29089_CR52) 2020; 178 29089_CR34 DG Gibson (29089_CR45) 2009; 6 SW Cho (29089_CR10) 2014; 24 D Burstein (29089_CR23) 2017; 542 Y Fu (29089_CR8) 2014; 32 P Chen (29089_CR16) 2020; 21 |
References_xml | – volume: 4 start-page: eaau0766 year: 2018 ident: CR42 article-title: Minimal PAM specificity of a highly similar SpCas9 ortholog publication-title: Sci. Adv. doi: 10.1126/sciadv.aau0766 – volume: 69 start-page: 59 year: 2020 end-page: 65 ident: CR19 article-title: A survey of genome editing activity for 16 Cas12a orthologs publication-title: Keio J. Med doi: 10.2302/kjm.2019-0009-OA – volume: 529 start-page: 490 year: 2016 end-page: 495 ident: CR7 article-title: High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects publication-title: Nature doi: 10.1038/nature16526 – volume: 351 start-page: 84 year: 2016 end-page: 88 ident: CR9 article-title: Rationally engineered Cas9 nucleases with improved specificity publication-title: Science doi: 10.1126/science.aad5227 – volume: 31 start-page: 833 year: 2013 end-page: 838 ident: CR28 article-title: CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2675 – volume: 337 start-page: 816 year: 2012 end-page: 821 ident: CR3 article-title: A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity publication-title: Science doi: 10.1126/science.1225829 – volume: 10 start-page: 1116 year: 2013 end-page: 1121 ident: CR22 article-title: Orthogonal Cas9 proteins for RNA-guided gene regulation and editing publication-title: Nat. Methods doi: 10.1038/nmeth.2681 – volume: 33 start-page: W244 year: 2005 end-page: W248 ident: CR37 article-title: The HHpred interactive server for protein homology detection and structure prediction publication-title: Nucleic Acids Res doi: 10.1093/nar/gki408 – volume: 20 year: 2019 ident: CR18 article-title: Enhanced mammalian genome editing by new Cas12a orthologs with optimized crRNA scaffolds publication-title: Genome Biol. doi: 10.1186/s13059-019-1620-8 – ident: CR21 – volume: 163 start-page: 759 year: 2015 end-page: 771 ident: CR17 article-title: Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system publication-title: Cell doi: 10.1016/j.cell.2015.09.038 – volume: 65 start-page: 618 year: 2017 end-page: 630 e617 ident: CR47 article-title: Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28 publication-title: Mol. Cell doi: 10.1016/j.molcel.2016.12.023 – volume: 339 start-page: 819 year: 2013 end-page: 823 ident: CR2 article-title: Multiplex genome engineering using CRISPR/Cas systems publication-title: Science doi: 10.1126/science.1231143 – volume: 8 year: 2017 ident: CR15 article-title: A thermostable Cas9 with increased lifetime in human plasma publication-title: Nat. Commun. doi: 10.1038/s41467-017-01408-4 – volume: 110 start-page: 15644 year: 2013 end-page: 15649 ident: CR12 article-title: Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1313587110 – volume: 551 start-page: 464 year: 2017 end-page: 471 ident: CR30 article-title: Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage publication-title: Nature doi: 10.1038/nature24644 – volume: 44 start-page: D862 year: 2016 end-page: D868 ident: CR31 article-title: ClinVar: public archive of interpretations of clinically relevant variants publication-title: Nucleic Acids Res doi: 10.1093/nar/gkv1222 – volume: 46 start-page: W246 year: 2018 end-page: W251 ident: CR35 article-title: CRISPRCasFinder, an update of CRISRFinder, includes a portable version, enhanced performance and integrates search for Cas proteins publication-title: Nucleic Acids Res doi: 10.1093/nar/gky425 – volume: 30 start-page: 3059 year: 2002 end-page: 3066 ident: CR39 article-title: MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform publication-title: Nucleic Acids Res doi: 10.1093/nar/gkf436 – volume: 34 start-page: i884 year: 2018 end-page: i890 ident: CR48 article-title: fastp: an ultra-fast all-in-one FASTQ preprocessor publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty560 – volume: 34 start-page: 184 year: 2016 end-page: 191 ident: CR6 article-title: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3437 – volume: 48 start-page: 12297 year: 2020 end-page: 12309 ident: CR14 article-title: PpCas9 from Pasteurella pneumotropica - a compact Type II-C Cas9 ortholog active in human cells publication-title: Nucleic Acids Res doi: 10.1093/nar/gkaa998 – volume: 125 start-page: 425 year: 2015 end-page: 436 ident: CR27 article-title: TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy publication-title: J. Clin. Invest doi: 10.1172/JCI78206 – volume: 16 start-page: 1511 year: 2021 end-page: 1547 ident: CR24 article-title: Scalable characterization of the PAM requirements of CRISPR-Cas enzymes using HT-PAMDA publication-title: Nat. Protoc. doi: 10.1038/s41596-020-00465-2 – volume: 30 start-page: 2808 year: 2014 end-page: 2810 ident: CR44 article-title: Sushi.R: flexible, quantitative and integrative genomic visualizations for publication-quality multi-panel figures publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu379 – volume: 157 start-page: 1262 year: 2014 end-page: 1278 ident: CR1 article-title: Development and applications of CRISPR-Cas9 for genome engineering publication-title: Cell doi: 10.1016/j.cell.2014.05.010 – volume: 33 start-page: 187 year: 2015 end-page: 197 ident: CR4 article-title: GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3117 – volume: 156 start-page: 935 year: 2014 end-page: 949 ident: CR26 article-title: Crystal structure of Cas9 in complex with guide RNA and target DNA publication-title: Cell doi: 10.1016/j.cell.2014.02.001 – volume: 35 start-page: 601 year: 2014 end-page: 608 ident: CR32 article-title: The mechanism by which TATA-box polymorphisms associated with human hereditary diseases influence interactions with the TATA-binding protein publication-title: Hum. Mutat. doi: 10.1002/humu.22535 – volume: 58 start-page: 102897 year: 2020 ident: CR25 article-title: An effective vaginal gel to deliver CRISPR/Cas9 system encapsulated in poly (beta-amino ester) nanoparticles for vaginal gene therapy publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.102897 – volume: 34 start-page: 483 year: 2016 ident: CR53 article-title: Open-source guideseq software for analysis of GUIDE-seq data publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3534 – volume: 523 start-page: 481 year: 2015 end-page: 485 ident: CR46 article-title: Engineered CRISPR-Cas9 nucleases with altered PAM specificities publication-title: Nature doi: 10.1038/nature14592 – volume: 6 start-page: 343 year: 2009 end-page: 345 ident: CR45 article-title: Enzymatic assembly of DNA molecules up to several hundred kilobases publication-title: Nat. Methods doi: 10.1038/nmeth.1318 – volume: 21 year: 2020 ident: CR16 article-title: A Cas12a ortholog with stringent PAM recognition followed by low off-target editing rates for genome editing publication-title: Genome Biol. doi: 10.1186/s13059-020-01989-2 – volume: 11 year: 2020 ident: CR40 article-title: A catalogue of biochemically diverse CRISPR-Cas9 orthologs publication-title: Nat. Commun. doi: 10.1038/s41467-020-19344-1 – volume: 3 start-page: eaao4774 year: 2017 ident: CR29 article-title: Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity publication-title: Sci. Adv. doi: 10.1126/sciadv.aao4774 – volume: 74 start-page: 117 year: 2009 end-page: 129 ident: CR33 article-title: TATA box polymorphisms in human gene promoters and associated hereditary pathologies publication-title: Biochem. (Mosc.) doi: 10.1134/S0006297909020011 – volume: 26 start-page: 1641 year: 2009 end-page: 1650 ident: CR38 article-title: FastTree: computing large minimum evolution trees with profiles instead of a distance matrix publication-title: Mol. Biol. Evol. doi: 10.1093/molbev/msp077 – volume: 24 start-page: 132 year: 2014 end-page: 141 ident: CR10 article-title: Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases publication-title: Genome Res doi: 10.1101/gr.162339.113 – volume: 14 start-page: 311 year: 2018 end-page: 316 ident: CR11 article-title: Partial DNA-guided Cas9 enables genome editing with reduced off-target activity publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.2559 – volume: 67 start-page: 1247 year: 2017 end-page: 1254 ident: CR20 article-title: Description of two novel members of the family Erysipelotrichaceae: Ileibacterium valens gen. nov., sp. nov. and Dubosiella newyorkensis, gen. nov., sp. nov., from the murine intestine, and emendation to the description of Faecalibaculum rodentium publication-title: Int J. Syst. Evol. Microbiol doi: 10.1099/ijsem.0.001793 – volume: 7 start-page: e40913 year: 2012 ident: CR41 article-title: Cleavage of phage DNA by the Streptococcus thermophilus CRISPR3-Cas system publication-title: PLoS ONE doi: 10.1371/journal.pone.0040913 – volume: 32 start-page: 170 year: 2011 end-page: 173 ident: CR36 article-title: NUPACK: Analysis and design of nucleic acid systems publication-title: J. Comput Chem. doi: 10.1002/jcc.21596 – volume: 178 start-page: 104794 year: 2020 ident: CR52 article-title: In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs’ cleavage by CRISPR/Cas13a system publication-title: Antivir. Res doi: 10.1016/j.antiviral.2020.104794 – volume: 8 year: 2017 ident: CR13 article-title: In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni publication-title: Nat. Commun. doi: 10.1038/ncomms14500 – volume: 542 start-page: 237 year: 2017 end-page: 241 ident: CR23 article-title: New CRISPR-Cas systems from uncultivated microbes publication-title: Nature doi: 10.1038/nature21059 – ident: CR34 – volume: 25 start-page: 1754 year: 2009 end-page: 1760 ident: CR50 article-title: Fast and accurate short read alignment with Burrows-Wheeler transform publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp324 – volume: 14 start-page: 858 year: 2018 end-page: 862 ident: CR51 article-title: CRISPRMatch: an automatic calculation and visualization tool for high-throughput CRISPR genome-editing data analysis publication-title: Int J. Biol. Sci. doi: 10.7150/ijbs.24581 – volume: 31 start-page: 827 year: 2013 end-page: 832 ident: CR5 article-title: DNA targeting specificity of RNA-guided Cas9 nucleases publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2647 – volume: 29 start-page: 15 year: 2013 end-page: 21 ident: CR43 article-title: STAR: ultrafast universal RNA-seq aligner publication-title: Bioinformatics doi: 10.1093/bioinformatics/bts635 – volume: 32 start-page: 279 year: 2014 end-page: 284 ident: CR8 article-title: Improving CRISPR-Cas nuclease specificity using truncated guide RNAs publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2808 – volume: 27 start-page: 2957 year: 2011 end-page: 2963 ident: CR49 article-title: FLASH: fast length adjustment of short reads to improve genome assemblies publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr507 – volume: 178 start-page: 104794 year: 2020 ident: 29089_CR52 publication-title: Antivir. Res doi: 10.1016/j.antiviral.2020.104794 – volume: 21 year: 2020 ident: 29089_CR16 publication-title: Genome Biol. doi: 10.1186/s13059-020-01989-2 – volume: 30 start-page: 3059 year: 2002 ident: 29089_CR39 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkf436 – volume: 529 start-page: 490 year: 2016 ident: 29089_CR7 publication-title: Nature doi: 10.1038/nature16526 – volume: 46 start-page: W246 year: 2018 ident: 29089_CR35 publication-title: Nucleic Acids Res doi: 10.1093/nar/gky425 – volume: 58 start-page: 102897 year: 2020 ident: 29089_CR25 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.102897 – volume: 8 year: 2017 ident: 29089_CR15 publication-title: Nat. Commun. doi: 10.1038/s41467-017-01408-4 – volume: 31 start-page: 833 year: 2013 ident: 29089_CR28 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2675 – volume: 44 start-page: D862 year: 2016 ident: 29089_CR31 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkv1222 – volume: 10 start-page: 1116 year: 2013 ident: 29089_CR22 publication-title: Nat. Methods doi: 10.1038/nmeth.2681 – volume: 163 start-page: 759 year: 2015 ident: 29089_CR17 publication-title: Cell doi: 10.1016/j.cell.2015.09.038 – volume: 35 start-page: 601 year: 2014 ident: 29089_CR32 publication-title: Hum. Mutat. doi: 10.1002/humu.22535 – volume: 16 start-page: 1511 year: 2021 ident: 29089_CR24 publication-title: Nat. Protoc. doi: 10.1038/s41596-020-00465-2 – volume: 8 year: 2017 ident: 29089_CR13 publication-title: Nat. Commun. doi: 10.1038/ncomms14500 – ident: 29089_CR34 doi: 10.1093/database/baz093 – volume: 27 start-page: 2957 year: 2011 ident: 29089_CR49 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr507 – volume: 48 start-page: 12297 year: 2020 ident: 29089_CR14 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkaa998 – volume: 65 start-page: 618 year: 2017 ident: 29089_CR47 publication-title: Mol. Cell doi: 10.1016/j.molcel.2016.12.023 – volume: 339 start-page: 819 year: 2013 ident: 29089_CR2 publication-title: Science doi: 10.1126/science.1231143 – volume: 32 start-page: 279 year: 2014 ident: 29089_CR8 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2808 – volume: 34 start-page: i884 year: 2018 ident: 29089_CR48 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty560 – ident: 29089_CR21 doi: 10.1101/pdb.prot086785 – volume: 32 start-page: 170 year: 2011 ident: 29089_CR36 publication-title: J. Comput Chem. doi: 10.1002/jcc.21596 – volume: 337 start-page: 816 year: 2012 ident: 29089_CR3 publication-title: Science doi: 10.1126/science.1225829 – volume: 74 start-page: 117 year: 2009 ident: 29089_CR33 publication-title: Biochem. (Mosc.) doi: 10.1134/S0006297909020011 – volume: 6 start-page: 343 year: 2009 ident: 29089_CR45 publication-title: Nat. Methods doi: 10.1038/nmeth.1318 – volume: 67 start-page: 1247 year: 2017 ident: 29089_CR20 publication-title: Int J. Syst. Evol. Microbiol doi: 10.1099/ijsem.0.001793 – volume: 24 start-page: 132 year: 2014 ident: 29089_CR10 publication-title: Genome Res doi: 10.1101/gr.162339.113 – volume: 69 start-page: 59 year: 2020 ident: 29089_CR19 publication-title: Keio J. Med doi: 10.2302/kjm.2019-0009-OA – volume: 523 start-page: 481 year: 2015 ident: 29089_CR46 publication-title: Nature doi: 10.1038/nature14592 – volume: 110 start-page: 15644 year: 2013 ident: 29089_CR12 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1313587110 – volume: 156 start-page: 935 year: 2014 ident: 29089_CR26 publication-title: Cell doi: 10.1016/j.cell.2014.02.001 – volume: 20 year: 2019 ident: 29089_CR18 publication-title: Genome Biol. doi: 10.1186/s13059-019-1620-8 – volume: 4 start-page: eaau0766 year: 2018 ident: 29089_CR42 publication-title: Sci. Adv. doi: 10.1126/sciadv.aau0766 – volume: 125 start-page: 425 year: 2015 ident: 29089_CR27 publication-title: J. Clin. Invest doi: 10.1172/JCI78206 – volume: 31 start-page: 827 year: 2013 ident: 29089_CR5 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2647 – volume: 542 start-page: 237 year: 2017 ident: 29089_CR23 publication-title: Nature doi: 10.1038/nature21059 – volume: 29 start-page: 15 year: 2013 ident: 29089_CR43 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bts635 – volume: 7 start-page: e40913 year: 2012 ident: 29089_CR41 publication-title: PLoS ONE doi: 10.1371/journal.pone.0040913 – volume: 30 start-page: 2808 year: 2014 ident: 29089_CR44 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu379 – volume: 34 start-page: 184 year: 2016 ident: 29089_CR6 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3437 – volume: 157 start-page: 1262 year: 2014 ident: 29089_CR1 publication-title: Cell doi: 10.1016/j.cell.2014.05.010 – volume: 3 start-page: eaao4774 year: 2017 ident: 29089_CR29 publication-title: Sci. Adv. doi: 10.1126/sciadv.aao4774 – volume: 11 year: 2020 ident: 29089_CR40 publication-title: Nat. Commun. doi: 10.1038/s41467-020-19344-1 – volume: 26 start-page: 1641 year: 2009 ident: 29089_CR38 publication-title: Mol. Biol. Evol. doi: 10.1093/molbev/msp077 – volume: 14 start-page: 858 year: 2018 ident: 29089_CR51 publication-title: Int J. Biol. Sci. doi: 10.7150/ijbs.24581 – volume: 34 start-page: 483 year: 2016 ident: 29089_CR53 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3534 – volume: 14 start-page: 311 year: 2018 ident: 29089_CR11 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.2559 – volume: 551 start-page: 464 year: 2017 ident: 29089_CR30 publication-title: Nature doi: 10.1038/nature24644 – volume: 351 start-page: 84 year: 2016 ident: 29089_CR9 publication-title: Science doi: 10.1126/science.aad5227 – volume: 25 start-page: 1754 year: 2009 ident: 29089_CR50 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp324 – volume: 33 start-page: W244 year: 2005 ident: 29089_CR37 publication-title: Nucleic Acids Res doi: 10.1093/nar/gki408 – volume: 33 start-page: 187 year: 2015 ident: 29089_CR4 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3117 |
SSID | ssj0000391844 |
Score | 2.5090892 |
Snippet | Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools... Gene editing tools have tremendous potential for biomedical and basic research. Here the authors report a Cas9 from Faecalibaculum rodentium (FrCas9) that... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1425 |
SubjectTerms | 631/1647/1511 631/337/4041/3196 631/61/201/2110 Accuracy Biotechnology CRISPR CRISPR-Associated Protein 9 - genetics CRISPR-Associated Protein 9 - metabolism CRISPR-Cas Systems - genetics Cutting tools Drug development Efficiency Fidelity Gene Editing - methods Genetic modification Genome Genome editing Genomes Humanities and Social Sciences Medical research multidisciplinary RNA, Guide, CRISPR-Cas Systems - genetics Science Science (multidisciplinary) |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na1QxEA9SKHgR6-eztUTwpo99-U6OunRZPYhUC72FfGJBXqW7PfjfO0nerl21evH2yAcMk0nymzeT3yD00tAstAxw-hmve85k7E00pKcxZeKypsFXts8PcnnG35-L8xulvkpOWKMHboqbCce8jjJwpTOXoswmUXAeAnwlGsrpC3feDWeqnsHMgOvCp1cyA9OzFa9nQklepyXW1eudm6gS9v8JZf6eLPlLxLReRIv76N6EIPGbJvkBupPGB2i_1ZT8_hAtF1dztzL4YoUdnp---_TxdFYbGmczLj9ecSEpxnBtlZxnnCqLRHmCid0YcS7EV4DNH6Gzxcnn-bKfyiX0AWDXugdfMybwrxj3TOgIuM4JE4Py3qSskzfCy4E5F1wmQ_Za6ixENDoNykjPFXuM9sbLMT1F2MioYgqehEC4j8IBjAQkp4ygypNIO0Q2qrNh4hIvJS2-2hrTZto2dVtQt63qtrpDr7ZzvjUmjb-OfltWZDuysGDXBrANO9mG_ZdtdOhos5522porCwgQICUFR6lDL7bdsKlKpMSN6fK6jQHgxtXQoSdt-beSMMFKfIp0SO0Yxo6ouz3jxZdK3A3YsLifHXq9MaGfYt2uimf_QxWH6C4ttl8yEdUR2ltfXafnAKfW_rjunB8Kphke priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BERIX1PIMbZGRuEG0SWzH9gnBitXCAaFCpb1ZfkIllC2b7YF_j8fJploevUWOIzkz4_Fnz_gbgJeqiVy2Lnk_ZWXJaOtL5VVdNj7E2kTZOJvZPj-1y3P2ccVX44FbP6ZV7nxidtR-7fCMfJYW7oQEmoRv31z-LLFqFEZXxxIat-EOUpdhSpdYiemMBdnPJWPjXZmKylnPsmfAFPYGI16l3FuPMm3_v7Dm3ymTf8RN83K0OIT7I44kbwfFH8Gt0D2Au0NlyV8PYbnYzE2vyEVPDJmfffjy-WyWGwbmZoLHrwSpiklavDDzmYTMJYEXMYnpPIlIf5UQ-iM4X7z_Ol-WY9GE0iXwtS3TjtOHtMuizFIufUJ3hivvhLUqRBms4ratqDHOxLqKVrYycu6VDJVQrWWCPoaDbt2Fp0BU64UPztbO1cx6bhKYTHhOKN4IW_umgHonOu1GRnEsbPFD58g2lXoQt07i1lncWhbwavrmcuDTuLH3O9TI1BO5sHPDevNNj1NLc0Ot9K1jQkbWcrSv2nPGnEtPoXEFnOz0qccJ2utrcyrgxfQ6TS2Ml5gurK-GPgm-MVEV8GRQ_zQSyilGqeoCxJ5h7A11_0138T3TdyeEiJvQAl7vTOh6WP8XxbOb_-IY7jVo1ZhpKE7gYLu5CqcJLm3t8zwnfgPYFhAh priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LixQxEC7WFcGL-LZ1lQjetNnuvHPUxmH0ILK6sLeQV-uC9MjM7GH__abSPS2jq-CtSVegqFSSr1KVLwCvDO2FliGvfsbrmjMZaxNNW9OY-tb1mgZf2D4_yeUp_3gmzg6A7u7ClKL9QmlZluldddjxhpcpjbXnFFNVtb4BN5G6Hb26k918roKM55rz6X5Mw_Q1Xff2oELVfx2-_LNM8rdcadmCFnfhzoQdydtR23twkIb7cGt8TfLyASwX685tDDnfEEe6kw9fPp8cl4aRrZngkStBemKSNyysdiap8Efg5Uvihkh6pLzKqPwhnC7ef-2W9fRQQh0y4NrWOcqMKUdWjHsmdMyIzgkTg_LepF4nb4SXDXMuuL5teq-l7oWIRqdGGem5Yo_gcFgN6QkQI6OKKfg2hJb7KFwGkBnDKSOo8m2kFbQ709kwsYjjYxY_bMlmM21Hc9tsblvMbXUFr-c-P0cOjX9Kv8MRmSWR_7o0rNbf7OQPVjjmdZSBK91zKdCn2ig4DyF_JRoqONqNp50m5cZm7JfBJM0hUgUv5995OmGOxA1pdTHKZMjGVVPB43H4Z02YYJiZaitQe46xp-r-n-H8e6HszqgQA88K3uxc6JdafzfF0_8Tfwa3KXo5VhuqIzjcri_S8wyZtv5FmSNXJOMN9Q priority: 102 providerName: Springer Nature |
Title | FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity |
URI | https://link.springer.com/article/10.1038/s41467-022-29089-8 https://www.ncbi.nlm.nih.gov/pubmed/35301321 https://www.proquest.com/docview/2640592675 https://www.proquest.com/docview/2640993470 https://pubmed.ncbi.nlm.nih.gov/PMC8931148 https://doaj.org/article/5a3b8d6c478f465f82c1d544cc82ce2c |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_tQ0i8IL4JjMpIvEFYE9ux_YBQV62USkxTR6W-Rf7KmDSl0HYS--85O0lRoSDxkkSOE1nnu9zvcvbvAF6rvOKysPj1U0amjBYuVU5lae58lelK5tZEts-zYjxjkzmf70FX7qgV4GpnaBfqSc2W1-9-fL_9gAb_vtkyLo9XLJp7WJeehzRWKvfhED2TCIb6uYX78ctMFQY0IdGc91mWou-m7T6a3a_Z8lWR0n8XDv1zOeVvOdXoqkb34V6LMcmgUYoHsOfrh3CnqTp5-wjGo-VQrxS5WhFNhtNPF-fT49jQsDqT8GuWBBpjgo4trIomPvJMhE2aRNeOVIEaC9H7Y5iNTr8Mx2lbUCG1CMzWKUajzmMERpmhXDpEfporZ4UxylfSG8VN0adaW11l_crIQlacOyV9X6jCMEGfwEG9qP0zIKpwwnlrMmszZhzXCDQR6wnFc2EylyeQdaIrbcs2HopeXJcx601l2Yi7RHGXUdylTODN5plvDdfGP3ufhBnZ9Aw82bFhsbwsW7MruaZGusIyIStW8KB7meOMWYtXPrcJHHXzWXa6VyJGRNCZYyiVwKvNbTS7kEvRtV_cNH0Q2jHRT-BpM_2bkVBOQwYrS0BsKcbWULfv1FdfI7U3oscQoCbwtlOhX8P6uyie_5fgXsDdPCh5WJQojuBgvbzxLxFZrU0P9sVc4FGOPvbgcDCYXEzwfHJ6dj7F1mEx7MV_Fr1oVj8B7xwfug |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKEYIL4s1CASPBCVbZh722DwhBIEpoqVBppdyMX9tWQpuSpEL9U_xGZry7qcKjt96iXSdyxjPjbzzjbwh5oYqay8qB91NWpqysfKq8ytPChzo3tSycjWyfu9X4gH2a8ukG-dXfhcGyyt4nRkftZw7PyAewcQMSKADfvj35kWLXKMyu9i00WrXYDmc_IWRbvJl8gPV9WRSjj_vDcdp1FUgdoJNlCiGZDxCGlMyWXHqAP4Yr74S1KtQyWMVtlZXGOFPnWW1lJWvOvZIhE6qyTJTwu1fIVdh4M7QoMRWrMx1kW5eMdXdzslIOFix6IiyZLzDDlsq1_S-2CfgXtv27RPOPPG3c_ka3yM0Ot9J3raLdJhuhuUOutZ0sz-6S8Wg-NAtFjxfU0OHe5OuXvUF80DJFUzzupUiNTGGzxEprGiJ3BV78pKbxtEa6LYgI7pGDSxHnfbLZzJrwkFBVeeGDs7lzObOeGwCvgB-F4oWwuS8Skvei065jMMdGGt91zKSXUrfi1iBuHcWtZUJerb5z0vJ3XDj6Pa7IaiRyb8cHs_mh7kxZc1Na6SvHhKxZxVGfc88Zcw4-hcIlZKtfT905hIU-V9-EPF-9BlPG_Ixpwuy0HQNwkYksIQ_a5V_NpOQlZsXyhIg1xVib6vqb5vgo0oUDIsWgNyGvexU6n9b_RfHo4n_xjFwf73_e0TuT3e3H5EaBGo5VjmKLbC7np-EJQLWlfRrtg5Jvl22QvwHZmE1U |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VIhAXxJuFAkaCE6ySXdtr-4AQpEQJRVVVqNSb69dCJbQpSSrUv8avY-zdTRUevfUW7TqRM54Zf-MZfwPwQpU1l5VD76eszBmtfK68KvLSh7owtSydTWyfu9XkgH085Icb8Ku_CxPLKnufmBy1n7l4Rj7AjRuRQIn4dlB3ZRF72-O3Jz_y2EEqZlr7dhqtiuyEs58Yvi3eTLdxrV-W5fjDl9Ek7zoM5A6RyjLH8MwHDEkos5RLj1DIcOWdsFaFWgaruK2G1Bhn6mJYW1nJmnOvZBgKVVkmKP7uFbgqKC-ijYlDsTrficzrkrHuns6QysGCJa8Uy-fLmG3L5dpemFoG_Avn_l2u-UfONm2F41tws8Ow5F2rdLdhIzR34Frb1fLsLkzG85FZKHK8IIaM9qef9_YH6UHLGk3i0S-JNMkEN85YdU1C4rGIl0CJaTypI_UWRgf34OBSxHkfNptZEx4CUZUXPjhbOFcw67lBIItYUiheClv4MoOiF512HZt5bKrxXaesOpW6FbdGceskbi0zeLX6zknL5XHh6PdxRVYjIw93ejCbf9WdWWtuqJW-ckzImlU86nbhOWPO4adQugy2-vXUnXNY6HNVzuD56jWadczVmCbMTtsxCB2ZGGbwoF3-1UwopzFDVmQg1hRjbarrb5rjb4k6HNFpDIAzeN2r0Pm0_i-KRxf_i2dwHU1Rf5ru7jyGG2VU8FjwKLZgczk_DU8QtS3t02QeBI4u2x5_A4o2UYo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FrCas9+is+a+CRISPR%2FCas9+system+with+high+editing+efficiency+and+fidelity&rft.jtitle=Nature+communications&rft.au=Cui%2C+Zifeng&rft.au=Tian%2C+Rui&rft.au=Huang%2C+Zhaoyue&rft.au=Jin%2C+Zhuang&rft.date=2022-03-17&rft.issn=2041-1723&rft.eissn=2041-1723&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-022-29089-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41467_022_29089_8 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |